
Join to View Full Profile
6700 W 115th StOverland Park, KS 66211
Phone+1 913-708-7555
Fax+1 913-708-7607
Are you Dr. Leese?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Philip Leese, MD is an internist in Overland Park, Kansas. He is currently licensed to practice medicine in Kansas.
Education & Training
- Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 1976 - 1979
- Creighton University School of MedicineClass of 1976
Certifications & Licensure
- KS State Medical License 1980 - 2022
Publications & Presentations
PubMed
- 6 citationsEffects of Fostamatinib on the Pharmacokinetics of the CYP2C8 Substrate Pioglitazone: Results From In Vitro and Phase 1 Clinical StudiesPaul D. Martin, Michael Gillen, David Millson, Stuart Oliver, Clive Brealey
Clinical Pharmacology in Drug Development. 2016-05-01 - 106 citationsOsimertinib Western and Asian clinical pharmacokinetics in patients and healthy volunteers: implications for formulation, dose, and dosing frequency in pivotal clinica...David Planchard, Kathryn H. Brown, Dong Wan Kim, Sang-We Kim, Yuichiro Ohe
Cancer Chemotherapy and Pharmacology. 2016-02-22 - 10 citationsAn open-label clinical trial of the effects of age and gender on the pharmacodynamics, pharmacokinetics and safety of the ghrelin receptor agonist anamorelin.Philip T. Leese, John M. Trang, Robert A. Blum, Eleanor de Groot
Clinical Pharmacology in Drug Development. 2015-03-01